Halil Taskaynatan

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|May 13, 2026
Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.

|Dec 30, 2025
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making.

Özlem Kutlu, Damla Günenç, Duygu Ayaz

|Nov 12, 2025
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy.

Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel

|Oct 14, 2025
Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy.

Halil Taskaynatan, Betul Ersoz, Ufuk Camanli

|Mar 23, 2022
Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review.

Ozlem Ozdemir, Baha Zengel, Yasar Yildiz

Pageof 1

Frequent Collaborators

3 joint publications

Ozlem Kutlu

2 joint publications

Ozlem Ozdemir

2 joint publications

Damla Günenç

1 joint publications

Baha Zengel